After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, ALKS falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Alkermes plc is $5.66B. A total of 1.14 million shares were traded on the day, compared to an average of 1.64M shares.
In the most recent transaction, Parisi Samuel Joseph sold 3,743 shares of ALKS for 35.26 per share on Feb 25 ’25. After the transaction, the VP, Finance (Interim PAO) now owns 7,717 company shares. In a previous transaction on Feb 20 ’25, Parisi Samuel Joseph sold 1,327 shares at 35.69 per share. ALKS shares that VP, Finance (Interim PAO) owns now total 7,717.
Among the insiders who sold shares, Hopkinson Craig C. disposed of 204,921 shares on Feb 12 ’25 at a per-share price of $32.78. This resulted in the EVP R&D, Chief Medical Officer holding 57,875 shares of ALKS after the transaction. In another insider transaction, Hopkinson Craig C. sold 144,419 shares at $35.53 per share on Feb 13 ’25. Company shares held by the EVP R&D, Chief Medical Officer now total 57,875.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, ALKS has a high of $36.45 and a low of $22.90.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. ALKS’s latest balance sheet shows that the firm has $536.31M in Cash & Short Term Investments as of fiscal 2021. There were $416.21M in debt and $471.29M in liabilities at the time. Its Book Value Per Share was $9.03, while its Total Shareholder’s Equity was $1.11B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALKS is Buy with a score of 4.20.
